162 related articles for article (PubMed ID: 22055840)
1. A-waves in Guillain-Barré syndrome: correlation with electrophysiological subtypes and antiganglioside antibodies.
Kawakami S; Sonoo M; Kadoya A; Chiba A; Shimizu T
Clin Neurophysiol; 2012 Jun; 123(6):1234-41. PubMed ID: 22055840
[TBL] [Abstract][Full Text] [Related]
2. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
[TBL] [Abstract][Full Text] [Related]
3. Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies.
Kuwabara S; Ogawara K; Mizobuchi K; Koga M; Mori M; Hattori T; Yuki N
J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):191-5. PubMed ID: 10644786
[TBL] [Abstract][Full Text] [Related]
4. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome.
Hiraga A; Kuwabara S; Ogawara K; Misawa S; Kanesaka T; Koga M; Yuki N; Hattori T; Mori M
Neurology; 2005 Mar; 64(5):856-60. PubMed ID: 15753422
[TBL] [Abstract][Full Text] [Related]
5. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
Kuwabara S; Yuki N; Koga M; Hattori T; Matsuura D; Miyake M; Noda M
Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542
[TBL] [Abstract][Full Text] [Related]
6. Conduction block in acute motor axonal neuropathy.
Kokubun N; Nishibayashi M; Uncini A; Odaka M; Hirata K; Yuki N
Brain; 2010 Oct; 133(10):2897-908. PubMed ID: 20855419
[TBL] [Abstract][Full Text] [Related]
7. Antiganglioside antibodies are associated with axonal Guillain-Barré syndrome: a Japanese-Italian collaborative study.
Sekiguchi Y; Uncini A; Yuki N; Misawa S; Notturno F; Nasu S; Kanai K; Noto Y; Fujimaki Y; Shibuya K; Ohmori S; Sato Y; Kuwabara S
J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):23-8. PubMed ID: 22010183
[TBL] [Abstract][Full Text] [Related]
8. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
9. Patterns of Guillain-Barre syndrome in children: results from a Mexican population.
Nachamkin I; Arzarte Barbosa P; Ung H; Lobato C; Gonzalez Rivera A; Rodriguez P; Garcia Briseno A; Cordero LM; Garcia Perea L; Perez JC; Ribera M; Aldama PC; Guitérrez GD; Sarnat LF; García MR; Veitch J; Fitzgerald C; Cornblath DR; Rodriguez Pinto M; Griffin JW; Willison HJ; Asbury AK; McKhann GM
Neurology; 2007 Oct; 69(17):1665-71. PubMed ID: 17898327
[TBL] [Abstract][Full Text] [Related]
10. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
11. Sensory nerve conduction in demyelinating and axonal Guillain-Barré syndromes.
Kuwabara S; Ogawara K; Misawa S; Mizobuchi K; Sung JY; Kitano Y; Mori M; Hattori T
Eur Neurol; 2004; 51(4):196-8. PubMed ID: 15159599
[TBL] [Abstract][Full Text] [Related]
12. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
13. A multicentre prospective study of Guillain-Barré syndrome in Japan: a focus on the incidence of subtypes.
Mitsui Y; Kusunoki S; Arimura K; Kaji R; Kanda T; Kuwabara S; Sonoo M; Takada K;
J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):110-4. PubMed ID: 24273220
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological subtypes and prognosis of Guillain-Barré syndrome in northeastern China.
Ye Y; Wang K; Deng F; Xing Y
Muscle Nerve; 2013 Jan; 47(1):68-71. PubMed ID: 23042578
[TBL] [Abstract][Full Text] [Related]
15. Electrodiagnostic and clinical aspects of Guillain-Barré syndrome: an analysis of 142 cases.
Gupta D; Nair M; Baheti NN; Sarma PS; Kuruvilla A;
J Clin Neuromuscul Dis; 2008 Dec; 10(2):42-51. PubMed ID: 19169089
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside.
Yuki N; Ang CW; Koga M; Jacobs BC; van Doorn PA; Hirata K; van der Meché FG
Ann Neurol; 2000 Mar; 47(3):314-21. PubMed ID: 10716250
[TBL] [Abstract][Full Text] [Related]
17. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
18. Conduction block--the diagnostic value in the early stage of Guillain-Barre syndrome.
Atanasova D; Ishpekova B; Muradyan N; Novachkova S; Daskalov M
Electromyogr Clin Neurophysiol; 2004 Sep; 44(6):361-4. PubMed ID: 15473348
[TBL] [Abstract][Full Text] [Related]
19. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiologic and immunopathologic correlates in Guillain-Barré syndrome subtypes.
Uncini A; Yuki N
Expert Rev Neurother; 2009 Jun; 9(6):869-84. PubMed ID: 19496690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
